List view / Grid view

R&D

 

Sanofi announces new Global Business Unit structure

15 July 2015 | By Victoria White

Sanofi plans to evolve its business with the creation of five Global Business Units: General Medicines & Emerging Markets, Specialty Care, Diabetes & Cardiovascular, Sanofi Pasteur and Merial.

Microfluidic chips: Lab-on-a-chip cell culture for metabolomics

3 July 2015 | By Laura A. Filla and James L. Edwards, Saint Louis University

Microfluidic devices (MFDs) have recently become popular as cell culture platforms for metabolomics due to reduced reagent requirements and the feasibility of flow-based studies. Such devices have the potential to transform pharmaceutical research by providing an online approach to high-throughput screening which can be coupled with a variety of analysis…

Send this to a friend